Michael Scolaro

Michael Scolaro

Sep 23, 2017

Group 6 Copy 253
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can cockroaches help us cure tularemia?

    Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

    Antibiotics and Affect: Avenues for Addiction Management

    Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several decades...

    Antibiotic Resistance: Between the Environment and Our Bodies

    Bacteria have evolved many genes to make them resistant to most of our antibiotics. Such genes can be moved...

    Backer Badge Funded